CLINICAL DIFFERENCES BETWEEN METOCLOPRAMIDE-INDUCED AND ANTIPSYCHOTIC-INDUCED TARDIVE DYSKINESIAS

被引:9
作者
LANG, AE
机构
[1] Movement Disorders Clinic, Toronto Western Hospital, Toronto
关键词
D O I
10.1017/S031716710003033X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A patient with tardive dyskinesia dominated by pelvic thrusting movements is described. A retrospective review of the clinical features documented in patients with metoclopramide- and antipsychotic-induced tardive dyskinesias seen over a six year period demonstrated that the occurrence of pronounced pelvic thrusting and respiratory dyskinesias were significantly more common in the metoclopramide treated group. The occurrence of bucco-linguomasticatory movements, limb stereotypies or chorea, and mild truncal or abdominal rocking were not significantly different between the two groups. None of the tardive dystonia patients had metoclopramide as the causative agent. These findings will require confirmation in larger, better matched patient populations. Whether the differences relate to different pharmacologic profiles of drug action, patient populations exposed, or other factors, remains to be elucidated. © 1990, Canadian Neurological Sciences Federation. All rights reserved.
引用
收藏
页码:137 / 139
页数:3
相关论文
共 29 条
[1]   EXTRAPYRAMIDAL REACTIONS WITH METOCLOPRAMIDE [J].
BATEMAN, DN ;
RAWLINS, MD ;
SIMPSON, JM .
BRITISH MEDICAL JOURNAL, 1985, 291 (6500) :930-932
[2]  
BEAUCLAIR L, 1986, CAN MED ASSOC J, V134, P613
[3]  
BOARD AW, 1987, NEW ENGL J MED, V316, P412
[4]  
BOARD AW, 1986, NEW ENGL J MED, V315, P518
[5]  
BREITBART W, 1986, NEW ENGL J MED, V315, P518
[6]   TARDIVE DYSTONIA - LATE-ONSET AND PERSISTENT DYSTONIA CAUSED BY ANTI-PSYCHOTIC DRUGS [J].
BURKE, RE ;
FAHN, S ;
JANKOVIC, J ;
MARSDEN, CD ;
LANG, AE ;
GOLLOMP, S ;
ILSON, J .
NEUROLOGY, 1982, 32 (12) :1335-1346
[7]  
CHOUINARD G, 1986, PSYCHOPHARMACOL BULL, V22, P259
[8]  
GRIMES JD, 1982, LANCET, V2, P563
[9]  
GRIMES JD, 1982, CAN MED ASSOC J, V126, P23
[10]   PHARMACOLOGICAL EVALUATION OF DOPAMINERGIC RECEPTOR BLOCKADE BY METOCLOPRAMIDE [J].
HASSAN, MN ;
RECHES, A ;
KUHN, C ;
HIGGINS, D ;
FAHN, S .
CLINICAL NEUROPHARMACOLOGY, 1986, 9 (01) :71-78